New York, New York 10065


The purpose of this study is to create a rapid scan of the pancreas and ovaries that could be used in the future to screen patients at risk for pancreatic or ovarian cancers. Currently, Magnetic Resonance Imaging (MRI) examinations of the pancreas and ovaries can last 30-45 minutes each. The investigators hope to create a rapid pancreatic and ovarian MRI evaluation that can be used as a screening tool that is completed in approximately 15 minutes. They will compare different tools available on modern MRI scanners to see which one reliably offers high quality images of the pancreas and ovaries.


Inclusion Criteria: - BRCA 1 or 2 mutation - Age ≥ 30 - Patients scheduled to undergo screening breast MRI with contrast Exclusion Criteria: - Patients with known breast cancer - Patients unable to complete their scheduled breast MRI - Patients with prior pancreatic surgery or cancers - Patients with prior ovarian cancer or surgery involving removal of one or both ovaries - Patients with prior abdominal or pelvic surgery



Primary Contact:

Principal Investigator
Peter Sawan, MD
Memorial Sloan Kettering Cancer Center

Peter Sawan, MD
Phone: 212-639-7121

Backup Contact:

Richard K.G. Do, MD, PhD
Phone: 212-639-8591

Location Contact:

New York, New York 10065
United States

Peter Sawan, MD
Phone: 212-639-7121

Site Status: Recruiting

Data Source:

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.